No abstract

Severe fever with thrombocytopenia syndrome is an emerging hemorrhagic fever disease with high mortality. Severe cases progressed rapidly, with deaths occurring within two weeks. Therefore, the construction of a model to predict the disease progression among hospitalized SFTS infected patients plays an important role in clinical practice. The development cohort including 121 SFTS patients, 25 were severe and 96 were mild. 2 of the 64 variables were independent risk factors, including neurological symptoms (OR, 12.915; 95% CI, P<0.